Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Johnson & Johnson
IndexDJIA S&P500 P/E19.15 EPS (ttm)5.23 Insider Own0.02% Shs Outstand2.83B Perf Week3.13%
Market Cap283.34B Forward P/E15.82 EPS next Y6.33 Insider Trans10.34% Shs Float2.83B Perf Month4.43%
Income15.06B PEG2.67 EPS next Q1.53 Inst Own66.60% Short Float1.10% Perf Quarter7.31%
Sales71.92B P/S3.94 EPS this Y24.60% Inst Trans-0.03% Short Ratio3.52 Perf Half Y10.89%
Book/sh25.76 P/B3.89 EPS next Y7.69% ROA11.90% Target Price104.55 Perf Year21.58%
Cash/sh10.33 P/C9.70 EPS next 5Y7.18% ROE21.50% 52W Range80.36 - 100.75 Perf YTD10.16%
Dividend2.64 P/FCF- EPS past 5Y1.00% ROI15.00% 52W High-0.68% Beta0.59
Dividend %2.64% Quick Ratio1.90 Sales past 5Y2.30% Gross Margin69.10% 52W Low24.52% ATR1.37
Employees128100 Current Ratio2.20 Sales Q/Q3.50% Oper. Margin28.10% RSI (14)68.01 Volatility1.26% 1.33%
OptionableYes Debt/Eq0.25 EPS Q/Q34.40% Profit Margin20.90% Rel Volume0.54 Prev Close100.18
ShortableYes LT Debt/Eq0.18 EarningsApr 15 BMO Payout49.70% Avg Volume8.84M Price100.07
Recom2.40 SMA201.96% SMA505.54% SMA2009.75% Volume3,790,258 Change-0.11%
17-Apr-14Reiterated Argus Buy $104 → $116
16-Apr-14Reiterated RBC Capital Mkts Outperform $104 → $106
10-Jan-14Downgrade Barclays Overweight → Equal Weight $99
07-Jan-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
16-Dec-13Reiterated Deutsche Bank Hold $93 → $95
18-Jul-13Reiterated Argus Buy $96 → $104
17-Jul-13Reiterated Barclays Overweight $95 → $99
17-Jul-13Downgrade Deutsche Bank Buy → Hold $92 → $93
18-Apr-13Reiterated Argus Buy $80 → $96
15-Apr-13Reiterated Barclays Overweight $85 → $95
12-Apr-13Reiterated Deutsche Bank Buy $82 → $87
26-Mar-13Reiterated UBS Buy $81 → $87
11-Jan-13Reiterated UBS Buy $76 → $78
04-Jan-13Upgrade Deutsche Bank Hold → Buy $75 → $82
20-Nov-12Initiated Stifel Nicolaus Hold
18-Jul-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
18-Apr-12Reiterated UBS Buy $71 → $70
12-Dec-11Reiterated UBS Buy $72 → $69
17-Oct-11Reiterated UBS Buy $74 → $72
24-Aug-11Reiterated Morgan Keegan Mkt Perform $70 → $68
23-Apr-14 02:18PM  [$$] More Consolidation in Cancer Space Expected at The Wall Street Journal
02:00PM  Johnson & Johnson to Host Medical Devices & Diagnostics Business Review PR Newswire
12:58PM  Hedge Funds Love These 5 Health Care Stocks -- but Should You? at TheStreet
08:56AM  The growing case for diversity as a profit source at CNBC
08:56AM  The growing case for diversity as a profit creator at CNBC
22-Apr-14 06:17PM  Gilead Revenue Soars on Hepatitis C Drug at New York Times
06:17PM  Gilead Revenue Soars on Hepatitis C Drug at New York Times
12:02PM  [video] Pharma's big deal frenzy at CNBC
10:36AM  Can This Dow Dividend Stock Recover from Disappointing Earnings? at Motley Fool
09:37AM  OxySure Systems Picks Up Momentum Going Into 2014 Accesswire
07:30AM  AstraZeneca (AZN) Jumps: Stock Adds 8.8% in Session Zacks
21-Apr-14 06:00PM  Roche Launches Kadcyla in Japan Zacks
04:15PM  How Johnson & Johnson Became A Household Name at Investopedia
03:07PM  Johnson & Johnson A Clear Pick In A Turbulent Market at Seeking Alpha
02:32PM  Warfarin's Loss is Johnson & Johnson's Gain at Motley Fool
12:07PM  Interesting May Stock Options For JNJ at TheStreet
10:50AM  [video] Pfizer considers AstraZeneca bid: Report at CNBC
08:48AM  Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making? at Motley Fool
08:12AM  Johnson & Johnson's Earnings Made Easy at Motley Fool
07:38AM  The Zacks Analyst Blog Highlights: JPMorgan, Pfizer, Coca-Cola, Johnson & Johnson and IBM Zacks
20-Apr-14 03:28AM  Why Johnson & Johnson's Patent Expiration Profile Is Fantastic at Seeking Alpha
19-Apr-14 03:00PM  How Big Is the Threat to This Johnson & Johnson Blockbuster? at Motley Fool
18-Apr-14 12:14PM  Earnings Roundup: Johnson & Johnson Results Are Better Than They Appear at Motley Fool
10:51AM  The Patent Drain on Economic Growth at Forbes
17-Apr-14 05:35PM  Glaxo Looking into Misconduct Charges Zacks
05:15PM  How Some Brands Come Back from Near Death at Investopedia
03:25PM  My Top Company For Income And Capital Gains at Seeking Alpha
02:32PM  Johnson & Johnson's 3 Major Strengths at Motley Fool
02:06PM  Business events scheduled for the coming week AP
10:14AM  New Recycling Study Shows Lack Of Bins Is No. 1 Barrier To Recycling In The Home PR Newswire
07:38AM  Ready For A Rebound? Gilead's $1000 Pill at Seeking Alpha
07:36AM  Earnings beats, lots of misses, hang over market at CNBC
16-Apr-14 06:48PM  Is Johnson & Johnson's Dividend Unbeatable? at Motley Fool
06:30PM  The Biggest Biotech Wins of the Week at Motley Fool
06:00PM  [video] Cramer's earnings edge at CNBC
04:36PM  Investor Steven Romick's Top 5 Increases of First Quarter Gurufocus
01:23PM  [video] China growing 'well enough': Pro at CNBC
01:00PM  Dow Today: Johnson & Johnson (JNJ) Lower at TheStreet
12:53PM  Smartphone apps to help patients take their meds AP
10:50AM  [video] Coke, Johnson & Johnson report earnings at CNBC
09:57AM  Will This Price Target Increase Help Johnson & Johnson (JNJ) Stock Today? at TheStreet
09:20AM  Stock Market News for April 16, 2014 Zacks
08:25AM  Does Johnson & Johnson Belong in Your Portfolio? at Wall St. Cheat Sheet
05:30AM  Reckitt leans towards pharmaceuticals spin-off Reuters
05:08AM  Why Johnson & Johnson Can Be Prescribed For Most Investors at Seeking Alpha
12:41AM  [$$] Sales of Johnson & Johnson's New Hepatitis C Drug Soar at The Wall Street Journal
12:09AM  [$$] Sales of Johnson & Johnson's New Hepatitis C Drug Soar at The Wall Street Journal
15-Apr-14 11:02PM  J&J Headache-Relieving Earnings, Coke's Healthy Earnings in Emerging Markets, and Yahoo!'s "Turnaround" Earnings at Motley Fool
10:41PM  [$$] Sales of Johnson & Johnson's New Hepatitis C Drug Soar at The Wall Street Journal
09:09PM  [$$] Sales of Johnson & Johnson's New Hepatitis C Drug Soar at The Wall Street Journal
09:06PM  Will Today's Earnings Send the Dow Jones Industrials to New Record Highs? at Motley Fool
08:15PM  Asia shares higher; Nikkei leads gains; China GDP eyed at CNBC
06:04PM  [video] Coca-Cola Shows Signs of a Rebound at Bloomberg
05:45PM  [video] Stock Pops & Drops: BCO, JNJ, P, NEM at CNBC
05:44PM  Heres Why Johnson & Johnson Had a Crazy Good First Quarter at Wall St. Cheat Sheet
05:26PM  [video] Coca-Cola 1Q Earnings Meet Estimates at Bloomberg
05:23PM  Stocks close higher as volatility returns at USA TODAY
04:51PM  Stocks close higher as volatility returns at USA TODAY
04:33PM  [audio] Newscast: Stocks notch win after choppy session at MarketWatch
04:30PM  Johnson & Johnson's Earnings Report Impresses at Motley Fool
04:25PM  [video] Markets Rise on Strong Earnings But Underlying Weakness Persists at TheStreet
04:22PM  On The Fly: Closing Wrap at theflyonthewall.com
04:18PM  Stocks Close In The Green After A Volatile Up-And-Down Day at Forbes
04:08PM  Stocks close higher as Ukraine crisis sparks volatility at USA TODAY
03:17PM  Stocks turn volatile amid rising Ukraine tensions at USA TODAY
02:56PM  This Forgotten Pharma Could Be a Hit for Your Portfolio at Motley Fool
02:45PM  VisionCare Appoints Industry Veterans, Mark Forchette, and John Ryan of ONSET Ventures to its Board of Directors PR Newswire
02:44PM  Stocks turn volatile amid rising Ukraine tensions at USA TODAY
02:41PM  Behind the stock market's whippy behavior at CNBC
02:40PM  Dow Fights Back Into the Green on Good Coke, J&J Numbers at Motley Fool
02:35PM  US stocks are mixed in afternoon trading AP
02:14PM  Volatility returns as stocks see big swings at USA TODAY
02:02PM  [video] Pisani worried about airlines at CNBC
01:44PM  Johnson & Johnson's Management Discusses Q1 2014 Results - Earnings Call Transcript Seeking Alpha
01:19PM  Another Earnings Beat from J&J, View Up Zacks
01:19PM  Heres Why Johnson & Johnson Had a Crazy Good First Quarter at Wall St. Cheat Sheet
01:16PM  [video] Johnson & Johnson Climbs After Beating Quarterly Estimates at TheStreet
01:10PM  [video] Calling the S&P's close at CNBC
12:58PM  On The Fly: Midday Wrap at theflyonthewall.com
12:58PM  Hearthside Group Holdings, LLC -- Moody's assigns B2 Corporate Family Rating to Hearthside; Outlook is stable at Moody's
12:33PM  J&J Q1 net up 8 percent on sales jump, lower costs AP
12:32PM  J&J beats forecasts as sales of new drugs shine Reuters
12:29PM  Stocks give up gains and tumble on Ukraine worries at USA TODAY
12:28PM  [video] Markets Fall as Tech Selloff Continues, China Woes Resume at TheStreet
12:17PM  [video] J&J healthy amid selloff at CNNMoney.com
12:00PM  Trading Range Or Stock Correction Remain Most Plausible Scenarios at Seeking Alpha
12:00PM  Jim Cramer: Why Johnson & Johnson (JNJ) and Coca-Cola (KO) Reported Surprising Results at TheStreet
11:59AM  Stocks give up gains and fall on Ukraine worries at USA TODAY
11:49AM  J&J beats forecasts as strong sales of new drugs shine Reuters
11:37AM  [video] Jim Cramer on Johnson & Johnson, Coca-Cola Earnings at TheStreet
11:17AM  J&J scoffs at patent cliff as pharma boosts firm's first-quarter earnings at MarketWatch
11:17AM  J&J Earnings Beat Estimates As Pharma Sales Shine at Investor's Business Daily
11:00AM  Dow Today: Johnson & Johnson (JNJ) Higher at TheStreet
10:18AM  Stocks scale back gains as after builder sentiment disappointss at CNBC
10:15AM  [video] Stocks Open Higher on Positive Earnings from J&J, Coca-Cola at TheStreet
10:10AM  Why Johnson & Johnson (JNJ) Stock Is Up Today at TheStreet
10:06AM  J&J beats forecasts, helped by new medicines at CNBC
10:01AM  Stocks move higher on encouraging profit reports at USA TODAY
09:59AM  Stocks to watch: KO, GMCR, JNJ, INTC, GE, GOOGL Hot Stock Minute
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fasolo PeterVP, Global Human ResourcesMar 14Sale93.156,824635,64015,647Mar 17 06:10 PM
Fasolo PeterVP, Global Human ResourcesMar 04Option Exercise62.6644,8612,811,19243,571Mar 05 06:18 PM
Ullmann Michael HVP, General CounselJan 10Option Exercise0.009,265065,448Jan 14 06:15 PM
Stoffels PaulusChief Scientific OfficerJan 10Option Exercise0.0018,690035,603Jan 14 06:03 PM
Gorsky AlexChairman, CEOJan 10Option Exercise0.0012,058081,579Jan 14 06:01 PM
Fasolo PeterVP, Worldwide Human ResourcesJan 10Option Exercise0.002,58809,310Jan 14 06:00 PM
COSGROVE STEPHEN JCorporate ControllerJan 10Option Exercise0.002,645090,804Jan 14 05:58 PM
Caruso Dominic JVP, Finance; CFOJan 10Option Exercise0.0012,121065,656Jan 14 05:56 PM
Ullmann Michael HVP, General CounselDec 13Option Exercise53.931,85099,77157,277Dec 16 06:18 PM
Fasolo PeterVP, Worldwide Human ResourcesNov 01Option Exercise0.008,620010,595Nov 05 10:58 AM
MULLIN LEO FDirectorOct 16Option Exercise53.937,600409,86830,752Oct 18 02:30 PM
COSGROVE STEPHEN JCorporate ControllerAug 14Option Exercise53.9325,0001,348,250107,451Aug 16 04:03 PM
COSGROVE STEPHEN JCorporate ControllerAug 14Sale91.3917,2001,571,90890,251Aug 16 04:03 PM
Ullmann Michael HVP, General CounselAug 05Option Exercise0.0020,650071,567Aug 06 05:28 PM
Ullmann Michael HVP, General CounselAug 05Sale93.6816,1401,511,99555,427Aug 06 05:28 PM
Stoffels PaulusChief Scientific OfficerJul 25Option Exercise65.8753,1683,502,32441,701Jul 29 05:51 PM
Stoffels PaulusChief Scientific OfficerJul 25Sale92.4045,4404,198,65612,533Jul 29 05:51 PM
Caruso Dominic JVP, Finance; CFOJul 18Option Exercise53.9330,0001,617,90083,534Jul 19 03:58 PM
Caruso Dominic JVP, Finance; CFOJul 18Sale90.3130,0002,709,30053,534Jul 19 03:58 PM
CULLEN JAMESDirectorMay 07Sale85.404,929420,9373,849May 08 03:31 PM